Myeloma pack: a new tool to lift Patients' spirits
NCT ID NCT03777306
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a structured educational program called the Myeloma Pack for people with multiple myeloma. The goal was to see if it could reduce anxiety and depression and improve quality of life. 85 patients took part while receiving standard cancer treatment. Researchers measured their anxiety and depression levels before, 12 weeks, and 24 weeks after the program.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
85 people
The number who actually took part.
- Started
-
Nov 2017
- Finished
-
Nov 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Of age ≥18 years or older. * Having a diagnosis of MM; newly diagnosed or relapsed/refractory disease * Undergoing systemic treatment through the UAB MM Clinic Pathway * Able to provide informed consent to be included in the intervention * MM patients in a prior/concurrent (non-pyscho/educational intervention), MM study will be eligible to participate * Have either SMS texting or email access to receive encouragement messages Exclusion Criteria: Patients will be ineligible for the program if they are: * Being treated by end-of-life or comfort care measures only * MM patients not treated through the UAB MM Clinic Pathway. * MM patients not requiring systemic therapy. * Patients with a diagnosis of MGUS or SMM. * Have a history of other malignancy within the past \[3 or 5\] years with the exception of: * Malignancies treated with curative intent and with no known active disease present for ≥ 3 (or 5) years before enrollment and felt to be at low risk for recurrence by the treating physician * Adequately treated non-melanoma skin cancer or lentigo maligna without evidence of disease * Adequately treated cervical carcinoma in situ without evidence of disease * Adequately treated breast ductal carcinoma in situ without evidence of disease * Prostatic intraepithelial neoplasia without evidence of prostate cancer * Adequately treated urothelial papillary noninvasive carcinoma or carcinoma in situ * Are enrolled in a prior/concurrent MM psycho-educational study Other Exclusions: * Patients who do not have either SMS texting or email access to receive encouragement messaging will be excluded * History or evidence of any other clinically significant disorder, condition or disease (with the exception of those outlined above) that, in the opinion of the investigator or Amgen physician, if consulted, would pose a risk to subject safety or interfere with the study evaluation, procedures or completion.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Multiple myeloma are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Alabama at Birmingham
Birmingham, Alabama, 35233, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Cheap blood count ratios eyed as window into Myeloma's inflammatory grip
- Can a t-cell engager rescue myeloma that outsmarted CAR-T?
- Can myeloma treatment work without steroids?
- Double-Drug attack on Hard-to-Treat lymphomas
- Banking blood and bone marrow to decode plasma cell disorders
- Which scan sees hidden myeloma better: PET or MRI?